ORMP Price / Book | ORAMED PHARMACEUTICALS INC.

ORAMED PHARMACEUTICALS INC. (ORMP) Price / Book

2026-09-03: Price/Book Ratio 0.65.
2026-06-30: Price/Book Ratio 0.63.
2026-03-31: Price/Book Ratio 0.58.
2025-12-31: Price/Book Ratio 0.56.

Historical market capitalization divided by filed shareholder equity.

Available history: 2011-08-31 to 2026-09-03
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2026-09-03	0.65
2026-06-30	0.63
2026-03-31	0.58
2025-12-31	0.56
2025-09-30	0.53
2025-06-30	0.59
2025-03-31	0.62
2024-12-31	0.66
2024-09-30	0.63
2024-06-30	0.59
2024-03-31	0.71
2023-12-31	0.57
2023-09-30	0.7
2023-06-30	0.95
2023-03-31	0.58
2022-12-31	3.14
2022-09-30	1.65
2022-06-30	1.15
2022-03-31	2.05
2021-12-31	3.27
2021-11-30	4.3
2021-09-30	6.3
2021-08-31	6
2021-06-30	4.5
2021-05-31	5.16
2021-03-31	4.41
2021-02-28	5.1
2020-12-31	2.59
2020-11-30	3.6
2020-08-31	2.51
2020-05-31	2.14
2020-02-29	5.86
2019-11-30	4.47
2019-08-31	2.98
2019-05-31	2.42
2019-02-28	2.19
2018-11-30	2.46
2018-08-31	2.76
2018-05-31	6.87
2018-02-28	5.1
2017-11-30	5.75
2017-08-31	6.15
2017-05-31	5.48
2017-02-28	3.77
2016-11-30	3.4
2016-08-31	3.63
2016-05-31	3.7
2016-02-29	2.84
2015-11-30	4.68
2015-08-31	2.62
2015-05-31	3.38
2015-02-28	2.19
2014-11-30	2.74
2014-08-31	4.93
2014-05-31	3.77
2014-02-28	6.23
2013-11-30	9.03
2013-08-31	7.12
2013-05-31	15.95
2013-02-28	12.39
2012-11-30	51.49
2012-08-31	6.78
2012-05-31	145.69
2012-02-29	98.33
2011-11-30	76.08
2011-08-31	65.53

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Zentalis Pharmaceuticals, Inc. (ZNTL)	United States	$0.196B	-2.48
Nkarta, Inc. (NKTX)	United States	$0.205B	-1.73
Fortress Biotech, Inc. (FBIO)	United States	$0.188B	0.91
ALX ONCOLOGY HOLDINGS INC (ALXO)	United States	$0.187B	-3.52
PepGen Inc. (PEPG)	United States	$0.186B	-1.73
AN2 Therapeutics, Inc. (ANTX)	United States	$0.185B	-4.84
Foghorn Therapeutics Inc. (FHTX)	United States	$0.213B	-4.43
Organogenesis Holdings Inc. (ORGO)	United States	$0.182B	-3.70
Eledon Pharmaceuticals, Inc. (ELDN)	United States	$0.219B	-3.23
Whitehawk Therapeutics, Inc. (WHWK)	United States	$0.221B